Sotorasib trials for Lung cancer

All Sotorasib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Sotorasib for Lung cancer

• A 2-part Phase 1/2 Open-label Trial on ODM-212
  NCT07563738 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
  NCT05920356 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 418 locations
• A Study of Sotorasib in People With Non-Small Cell Lung Cancer
  NCT06582771 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
  NCT06249282 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
  NCT05398094 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
  NCT06532149 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Ladarixin With Sotorasib in Advanced NSCLC
  NCT05815173 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 6 locations
• Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
  NCT07012031 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations

Common questions

How many trials study Sotorasib for Lung cancer?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.